GRANITE FALLS, NC, June 24, 2025 /24-7PressRelease/ -- Ranga Namburi has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Namburi has established a distinguished career in the pharmaceutical industry, marked by significant contributions to drug delivery technologies. As a pharmaceutical consultant at Aaryen Pharma since 2023, he has been instrumental in consulting for a mid-size company and developing an extended-release dosage form for a pharmaceutical industry. Dr. Namburi's expertise in product development and regulatory compliance for pharmaceuticals is widely recognized, underscoring his commitment to advancing the field of pharmacy.

Before his work at Aaryen Pharma, Dr. Namburi served as the research and development director at KVK from 2013 to 2023. Before joining KVK, he held the position of chief technical officer at Cispharma. In this capacity, he was responsible for overseeing technical operations and ensuring compliance with regulatory standards. Earlier in his career, Dr. Namburi served as the vice president at QPharma LLC, where he refined his skills in compliance solutions. Dr. Namburi has worked for a very large pharmaceutical company, DSM Pharmaceuticals, developing pharmaceutical dosage forms. Dr. Namburi has been granted a couple of US Patents as an inventor. He has several publications in scientific journals of international repute.

Dr. Namburi's academic background laid a strong foundation for his professional accomplishments. He earned a Bachelor of Science and Master of Science in pharmacy, followed by a Doctor of Philosophy in pharmaceutical sciences from Andhra University in 1980.

Active in his professional community, Dr. Namburi is a member of the American Association of Pharmaceutical Scientists. He is also civically engaged within various local organizations and initiatives. These affiliations reflect his dedication to both scientific advancement and community engagement.

Throughout his tenure in the pharmaceutical sector, Dr. Namburi successfully developed products that met clinical requirements, leading to the successful filing and approval of new drug applications, ANDA generic prescription drug products, and several of over-the-counter medicines with the Food and Drug Administration (FDA). This has served as a testament to his proficiency in navigating complex regulatory landscapes. Meanwhile, Dr. Namburi's work on biomodeling and enhancing the solubility of poorly water-soluble drugs significantly improved their absorption when orally administered, marking some of his most notable achievements. Additionally, he played a key role in remediation programs, helping companies address quality system issues with the FDA to ensure compliance.

Looking toward future opportunities, Dr. Namburi aims to continue enhancing patient care by improving drug delivery systems to ensure maximum efficacy with minimal side effects, while remaining actively involved in the development of new drug products.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #